glp 1 drugs type 1 diabetes More people with are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness A Guide to GLP-1s: Resources
Description
No doctors visit required, no insurance required
Semaglutide, manufactured by Novo Nordisk and sold under the brands Ozempic and Wegovy, as treatment for type 2 diabetes (T2D) and obesity, respectively, was one of the catalysts behind the growth of the GLP-1RA market
Other than Trulicity, there are two other once-weekly GLP-1 agonists currently available: AstraZenecas Bydureon (exenatide) and GlaxoSmithKlines Tanzeum/Eperzan (albiglutide)
Since GLP-RAs were created primarily for the treatment of T2DM, their effect on blood glucose will be discussed first, followed by their effect on weight management and obesity
doi: 10.1126/science.adj2537
